CHICAGO, Sept. 16, 2020 /PRNewswire/ -- EVERSANA™, the
leading provider of global commercial services to the life sciences
industry, today launched ACTICS by EVERSANA™, the
technology-enabled solution to optimize end-to-end commercial
success for life science companies. Combining the power of
AI-driven predictive analytics with ready-to-deploy, real-time
commercial services, ACTICS provides the cloud-based
solution pharmaceutical innovators need to optimize actions in the
product and patient journeys.
Leveraging proprietary and integrated data, ACTICS is
built on a data-mastering platform and cloud-based infrastructure,
enabling the ability to combine multiple data sources into a
comprehensive and actionable system. Through API-driven automated
intelligence and machine learning technology, ACTICS feeds
downstream alerts to additional cloud-based infrastructure, such as
a client's CRM system, to create actionable insights.
Further complemented by wrap-around data science services and
subscription-based offerings, clients can power their commercial
success through the complete ACTICS solution, which, when
paired with EVERSANA's integrated commercial services, will
integrate and analyze all data points and then trigger and
influence real-time actions to drive value across the care
continuum.
"EVERSANA now delivers on the full promise of real-time
intelligence driving next best actions across the therapeutic and
patient journeys," said Brigham
Hyde, president, Data & Analytics, EVERSANA. "We've made
the aggressive investments in technology, data and people to
activate data-driven engagement to advance access and adherence at
each stage of the product life cycle."
As a scalable solution, ACTICS can also solve specific
commercial challenges, such as optimizing market access, evidence
creation or patient-finding barriers. Clients can leverage select
ACTICS capabilities, including project-based data science
services, data accessibility and platform licenses for
subscription-based modules and platform applications.
Development of the ACTICS solution was expedited after
EVERSANA's acquisition of HVH Precision Analytics and its
predictive analytics platform in July
2020. ACTICS is being leveraged into the launch and
commercialization strategies for multiple pharmaceutical and
digital therapies and works seamlessly with EVERSANA's integrated
commercial services platform designed to solve global pricing,
access, reimbursement, real-world evidence, adherence and product
delivery challenges in the life science sector.
"This marks a transformative moment for next-generation
commercial services. No other service provider has the data and
analytics platform paired with fully integrated commercial services
to trigger, optimize and measure value for clients, their
portfolios and their patients," said Jim
Lang, CEO, EVERSANA.
For more information, visit eversana.com.
About EVERSANA™
EVERSANA™ is the leading independent provider of global services
to the life sciences industry. The company's integrated solutions
are rooted in the patient experience and span all stages of the
product life cycle to deliver long-term, sustainable value for
patients, prescribers, channel partners and payers. The company
serves more than 500 organizations, including innovative start-ups
and established pharmaceutical companies, to advance life science
solutions for a healthier world. To learn more about EVERSANA,
visit eversana.com or connect
through LinkedIn and Twitter.
CONTACT:
Sarah Zwicky
sarah.zwicky@eversana.com
414.434.4691
View original content to download
multimedia:http://www.prnewswire.com/news-releases/eversana-launches-actics-by-eversana-the-technology-enabled-solution-combining-predictive-analytics-integrated-with-real-time-commercial-services-to-drive-next-best-action-in-the-life-science-sector-301132092.html
SOURCE Eversana